• Oxurion NV appoints Tom Graney, CFA as Chief Executive Officer

    Monday May 17th 2021

  • Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski

    Tuesday May 11th 2021

  • Biotalys appoints Simon Moroney as Chairman of the Board

    Wednesday April 21st 2021

  • Celyad Oncology appoints Dr. Charles Morris as Chief Medical Officer

    Tuesday April 20th 2021

  • 'We went here, there and everywhere to make it happen'

    Thursday April 8th 2021

  • Montis Biosciences appoints RenĂ© Hoet as Chief Scientific Officer

    Thursday April 1st 2021

  • Bone Therapeutics appoints industry cell therapy expert, Anthony Ting, PhD as Chief Scientific Officer

    Wednesday March 31st 2021

  • Galapagos appoints Bart Filius as President and Chief Operating Officer

    Thursday March 25th 2021

  • Your news here?

  • Augustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board

    Friday March 19th 2021

  • reMYND appoints Dr. Lode Debrabandere as Chief Business Officer

    Thursday March 18th 2021

  • Augustine Therapeutics appoints Sylvain Celanire as CEO to accelerate development of innovative medicines for rare neuromuscular diseases

    Thursday March 18th 2021


Strategic Partners